Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

A new compound effectively inhibits human 5α-reductase 1.

ADF8 and ADF11 help root hairs grow by responding to hormones and environmental signals.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Electric Follicle Stimulation may promote hair growth and density with no known side effects.

The diphosphonate was the most effective at preventing calcification in rats.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Caribine from traditional Chinese medicine may help treat hair loss.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

EBV infection increases a specific keratin variant in carcinoma cells, possibly affecting cell structure and cancer progression.

Stopping finasteride improved seizure control, suggesting neurosteroids affect seizures and treatment.

Tectoridin helps human hair cells grow and makes mouse hair longer, suggesting it could treat hair loss.

Rebamipide may help regrow hair by activating hair follicle stem cells.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Baricitinib works better than methotrexate for severe alopecia areata.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Laser and Eflornithine are more effective for hair removal than traditional methods.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.